~~<i id='3337987114'><strike id='3337987114'><tt id='3337987114'><pre id='3337987114'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：focus 2025-09-30 00:47:08 - browse：26

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Wikipedia

hotspot

focus

knowledge

hotspot

AdobeYou’rereadingthewebversionofHealthCareInc.,STAT’sweeklynewsletterfollowingtheflowofmoneyinmedic

WSS

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Better Therapeutics data on benefit with GLP

ALS patient reclaims some autonomy thanks to wearable 'robot'

How clinical AI models' predictive power can degrade over time

How should state employee insurance handle Wegovy?

There’s no way to know how good AI health technologies are

leisure time

knowledge

Wikipedia

At least 13 dead in Texas as scorching temps continue

Researchers CRISPR chickens in bid to protect them from bird flu

23andMe had bad news about my health. I wish a person had delivered it

Coercive sterilizations revealed by STAT prompt outrage

Medicare details structure of new drug price negotiation program

5 takeaways from STAT's examination of Zynex Medical

Medical leaders decry Supreme Court decision on affirmative action

European regulators consider appeal over Amylyx ALS drug

Jerome Adams on the need for new antivirals for Covid

Cigna wins case to block Amy Bricker's move to CVS

hotspot

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

European regulators consider appeal over Amylyx ALS drug

My daughter's legacy lives on through her writing, phage therapy

Life sciences deals on track to hit lowest point since 2017

A revolution in caring for preterm infants

How should state employee insurance handle Wegovy?

hotspot

focus

knowledge

hotspot